What is the recommended treatment for a child with pneumonia, considering age and severity of symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Pneumonia in Children

Oral amoxicillin at 90 mg/kg/day divided into 2 doses is the first-line treatment for children under 5 years with community-acquired pneumonia, while macrolide antibiotics (azithromycin or clarithromycin) are recommended as first-line for children 5 years and older. 1, 2

Age-Based Treatment Algorithm

Children Under 5 Years (Preschool Age)

For outpatient management:

  • Amoxicillin 90 mg/kg/day divided into 2 doses for 5 days is the definitive first-line choice 1, 2
  • This provides optimal coverage against Streptococcus pneumoniae, the most common bacterial pathogen in this age group 1, 2
  • Alternative agents if amoxicillin cannot be used: amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component in 2 doses) 1

For hospitalized children:

  • Fully immunized with minimal local penicillin resistance: IV ampicillin or penicillin G 1
  • Not fully immunized or significant local resistance: IV ceftriaxone or cefotaxime 1
  • Add vancomycin or clindamycin if community-associated MRSA is suspected 1

Children 5 Years and Older

For outpatient management:

  • Macrolide antibiotics are first-line: azithromycin 10 mg/kg on day 1, then 5 mg/kg daily on days 2-5 (maximum 500 mg day 1, then 250 mg days 2-5) 1, 2, 3
  • Alternative macrolides: clarithromycin 15 mg/kg/day in 2 doses for 7-14 days, or erythromycin 1
  • If bacterial pneumonia is strongly suspected (rather than atypical): amoxicillin 90 mg/kg/day in 2 doses (maximum 4 g/day) 1, 2
  • When bacterial versus atypical pneumonia cannot be distinguished clinically, add a macrolide to amoxicillin for empiric coverage 1

For hospitalized children:

  • Same IV beta-lactam approach as younger children (ampicillin/penicillin G or ceftriaxone/cefotaxime based on immunization status and local resistance) 1
  • Add azithromycin if atypical pneumonia (Mycoplasma or Chlamydophila) cannot be excluded 1

Severity-Based Hospitalization Criteria

Hospitalize immediately if ANY of the following are present:

  • Age less than 2 months (all pneumonia in this age group is severe by definition) 1, 4
  • Oxygen saturation <92% on room air 1, 2, 5
  • Moderate to severe respiratory distress (lower chest indrawing, grunting, nasal flaring) 1, 2, 5
  • Inability to tolerate oral medications, persistent vomiting, or dehydration 1, 2
  • Failure to respond to oral antibiotics within 48-72 hours 1, 2
  • IMCI danger signs: inability to drink/breastfeed, convulsions, lethargy, or unconsciousness 1

Treatment Duration and Monitoring

Standard treatment course:

  • 5 days for most cases of community-acquired pneumonia 2
  • 3-day courses may be acceptable in areas with low HIV prevalence for non-severe pneumonia 1
  • In high HIV prevalence areas, use 5-day courses regardless of co-trimoxazole prophylaxis status 1, 2

Reassessment timeline:

  • All children must be re-evaluated at 48-72 hours if they remain febrile or show no clinical improvement 1, 2, 5
  • Expect clinical improvement (decreased fever, improved respiratory rate, decreased work of breathing) within this timeframe 1, 5

Management of Treatment Failure

If no improvement at 48-72 hours, escalate as follows:

  • Broaden antibiotic coverage to amoxicillin-clavulanate, ceftriaxone, or cefuroxime 2, 6
  • Add macrolide coverage if not already included and atypical pathogens are suspected 2, 6
  • Perform further investigation including chest radiography if not already done 1
  • Consider complications: parapneumonic effusion, empyema, or necrotizing pneumonia 1, 5
  • In high HIV prevalence areas, refer for HIV testing and broad-spectrum parenteral antibiotics 1, 2

Supportive Care Measures

Oxygen therapy:

  • Maintain oxygen saturation >92% using nasal cannula, head box, or face mask 2, 5
  • Monitor oxygen saturation at least every 4 hours in hospitalized children on oxygen 5

Hydration and comfort:

  • Ensure adequate oral hydration in outpatients 5
  • IV fluids at 80% of basal requirements if needed, with electrolyte monitoring 5, 6
  • Antipyretics and analgesics to maintain comfort and help with coughing 2, 5

Critical Pitfalls to Avoid

Do NOT perform chest physiotherapy - it provides no benefit and should not be done in children with pneumonia 2, 5

Avoid nasogastric tubes in severely ill infants - they may compromise breathing, especially in young infants 5

Do not routinely obtain follow-up chest radiographs in children who are clinically improving 5

Do not use antibiotics routinely for presumed viral pneumonia in well-appearing preschool children with mild symptoms 5

Never rely on azithromycin alone to treat syphilis in adolescents with sexually transmitted infections - always perform serologic testing 3

Special Populations

Infants ≤8 weeks:

  • All pneumonia in this age group requires hospitalization with parenteral antibiotics for at least 8 days 4
  • Careful monitoring of body temperature and serum glucose is essential 4
  • This age group has the highest mortality and requires most urgent attention 4

Children with HIV or high HIV prevalence areas:

  • Amoxicillin remains first-line regardless of co-trimoxazole prophylaxis 1, 2
  • Use 5-day treatment courses 1
  • Lower threshold for hospitalization and broader-spectrum antibiotics if treatment fails 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

First-Line Treatment for Pneumonia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of pneumonia in the child aged 0 to 8 weeks.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2005

Guideline

Management of Pediatric Viral Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Pneumonia in Children with Asthma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.